SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

194 hedge funds and large institutions have $458M invested in Sangamo Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 28 closing their positions.

Holders
194
Holders Change
+1
Holders Change %
+0.52%
% of All Funds
3.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
57
Reduced
56
Closed
28
Calls
$3.64M
Puts
$1.95M
Net Calls
+$1.69M
Net Calls Change
-$783K

Top Buyers

1
State Street
1
State Street
Massachusetts
$45.2M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$5.07M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$58.9M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$16.5M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$6.3M

Top Sellers

1
LOAMS
1
Lombard Odier Asset Management (Switzerland)
Switzerland
$5M
2
Millennium Management
2
Millennium Management
New York
$4.01M
3
Morgan Stanley
3
Morgan Stanley
New York
$4.99M
4
PAM
4
Panagora Asset Management
Massachusetts
$1.16M
5
WA
5
Wasatch Advisors
Utah
$61.5M
Name Market Value Shares Shares
Change 		Shares
Change %
TCM
226
Tradewinds Capital Management
Washington
$0 10 – –
Parallax Volatility Advisers
227
Parallax Volatility Advisers
California
– – – –
CG
228
Cutler Group
California
– – – –
6 7 8 9
10